313 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABT Abbott Laboratories $67.67 $118.71B Downtrend
Article Searches
Abbott Laboratories (ABT) CEO Miles White on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4254989-abbott-laboratories-abt-ceo-miles-white-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare Apr 17, 2019 - Abbott Laboratories (NYSE:ABT) Q1 2019 Earnings Conference Call April 17, 2019 9:00 am ET Company Participants Miles White - Chairman, Chief Executive Officer Robert Ford - President, Chief Operating
Abbott (ABT) Q1 Earnings Beat Estimates, Organic Sales Solid http://www.zacks.com/stock/news/386433/abbott-abt-q1-earnings-beat-estimates-organic-sales-solid?cid=CS-ZC-FT-386433 Apr 17, 2019 - Abbott (ABT) reports strong and consistent EPD and Medical Devices performance organically in Q1.
Thermo Fisher to Buy Brammer Bio, Tightens Gene Therapy Grip http://www.zacks.com/stock/news/364388/thermo-fisher-to-buy-brammer-bio-tightens-gene-therapy-grip?cid=CS-ZC-FT-364388 Mar 25, 2019 - On closure of the acquisition deal, Brammer Bio will be integral to Thermo Fisher's (TMO) pharma services business within its Laboratory Products and Services wing.
Abbott's New CE Mark to Boost Core Laboratory Diagnostics Arm http://www.zacks.com/stock/news/364189/abbotts-new-ce-mark-to-boost-core-laboratory-diagnostics-arm?cid=CS-ZC-FT-364189 Mar 25, 2019 - Abbott's (ABT) Alinity m diagnostics system and assays will provide increased flexibility and time efficiency while catering to the rising demand for infectious disease testing.
Quest Diagnostics Grows on New Pacts Amid Reimbursement Issue http://www.zacks.com/stock/news/364204/quest-diagnostics-grows-on-new-pacts-amid-reimbursement-issue?cid=CS-ZC-FT-364204 Mar 25, 2019 - Quest Diagnostics' (DGX) partnership with UnitedHealthcare to operate as a preferred national laboratory seems strategic for the latter's customers.
6 Excellent Dividend Growth Stocks to Buy Now http://www.zacks.com/stock/news/364113/6-excellent-dividend-growth-stocks-to-buy-now?cid=CS-ZC-FT-364113 Mar 25, 2019 - The return of volatility with the escalation of global growth concerns and the risk of recession in the United States raises the appeal for dividend growth stocks.
Varian (VAR) Scales New 52-Week High on Solid Prospects http://www.zacks.com/stock/news/363525/varian-var-scales-new-52-week-high-on-solid-prospects?cid=CS-ZC-FT-363525 Mar 22, 2019 - The key growth driving factor for Varian (VAR) in the past year has been increasing net sales from major business segments.
Here's Why DexCom Shares Are Dropping Today https://www.fool.com/investing/2019/03/22/heres-why-dexcom-is-dropping-by-double-digits-toda.aspx?source=iedfolrf0000001 Mar 22, 2019 - The stock falls hard after a short-seller takes aim at the company.
Baxter (BAX) Soars to 52-Week High, Time to Cash Out? http://www.zacks.com/stock/news/363132/baxter-bax-soars-to-52-week-high-time-to-cash-out?cid=CS-ZC-FT-363132 Mar 22, 2019 - Baxter (BAX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results http://www.zacks.com/stock/news/362778/abbotts-abt-heartmate-3-pump-study-shows-favorable-results?cid=CS-ZC-FT-362778 Mar 21, 2019 - The use of Abbott's (ABT) HeartMate 3 pump can efficiently prolong life -term and improve the quality of life for advanced heart failure patients.

Pages: 123456...32

Page 1>